Is your manufacturing outsourcing model filled with operational bottlenecks, delays in the production cycle, or sudden regulatory challenges? Third Party Manufacturing should be careful about the batch consistency, supply chain efficiency & availability of raw materials. A competent manufacturing partner will enable you to develop your pharmaceutical business while protecting investments.
Outsourcing is a proven strategy for reducing capital expenses and achieving lean operations in the pharmaceutical business. Yet, unregulated pharma manufacturing risks can quickly damage your brand’s reputation.
Below, you will find a full list of third party manufacturing challenges, some risk reduction methods, and solutions for efficient pharma production.
Contact Us: +(91) – 9412054069
What Are the Most Common Issues in Third Party Manufacturing?
Quality and Compliance Fluctuations
The presence of impurities in the raw material can also lead to batch rejection during quality control tests. Furthermore, non-conformity with the newly adopted WHO-GMP or Revised Schedule M standards leads to punitive actions against pharmaceutical companies.
Production Delays and Lead Time Obstacles
Unforeseen supply chain disruptions and poor factory floor scheduling result in stock shortages. As a consequence, delays in dispatch of essential tablet/syrup batches damage relationships with doctors and retail distributors.
Hidden Costs and Margins Reduction
Vague contract terms bring additional costs for second-stage packaging, lab testing or freight shipping. Unpredicted changes to initial estimates reduce the net profitability of expanding pharmaceutical companies.
Risks of Intellectual Property Theft
Outsourcing your proprietary drug formulas without proper non-disclosure agreements entails formula leakage. Moreover, delayed filing of regulatory documents such as DCGI approval affects the commercial launch schedule of the product.
Inefficiency of Technical Support
Poor technical collaboration between clients and plant staff causes delays in requests for batch customization. In addition, lack of prompt communication about shortages of raw materials makes it hard for Third Party Pharma Manufacturers to develop a proactive strategy in the market.
How Can Businesses Handle Quality and Compliance Issues with Third Party Manufacturing?
| Challenge Area | Root Cause | Possible Solution |
|---|---|---|
| Substandard Raw Materials | Lack of verification of API vendors | Strict vendor audits and CoA testing |
| Regulatory Non-Compliance | Lack of adaptation to updated Schedule M requirements | Employment of only WHO-GMP & ISO 9001 certified units |
| Batch-to-Batch Variations | Variations in SOPs | Use of automation and regular quality control |
| Risk of Packaging Defects | Low-quality blister packs and ALU-ALU foils | Use of moisture-resistant packaging materials |
Visit Us At: F-109, 110, UPSIDC, Industrial Area, Central Hope Town, Selaqui, Dehradun
How Can You Prevent Delays and Miscommunication in Third Party Manufacturing?
Preventive measures against delays in operations during the Pharma Manufacturing process of the pharmaceutical product include effective forecasting of the supply chain and direct communication systems. Firms have to consider the timelines and create safety stock provisions for the important ranges.
- SLAs have to be put in place indicating the time of shipment for each batch.
- A monthly review has to take place to see if raw materials are available.
- Processes involved in producing each batch have to be verified using digital stock information.
- The assignment of account managers has to be made to make communication easier between the client and manufacturer.
- Provision of safety stocks has to be made for fast-moving oral solids/liquids.
How Can Daffohils Laboratories Resolve Your Third Party Manufacturing Challenges?
WHO-GMP Certified Production Units
Daffohils Laboratories has a modern, state-of-the-art infrastructure that meets WHO-GMP and ISO standards. Its modern pharma manufacturing technology guarantees strict conformity with national and international standards of pharmaceutical product quality.
Multi-Level Quality Assurance Procedure
The company ensures a multi-stage quality control process from raw material sourcing to batch dispatch. Physical, chemical, and microbiological tests are carried out by specialized testing labs to ensure total batch purity.
High Scalability and Transparent Prices
Daffohils Laboratories offer flexibility in manufacturing capacities, ranging from pilot batches to commercial ones. They have a clear pricing policy without hidden charges to help their clients maintain profitable margins.
Wide Range of Formulations
Clients get access to a wide range of products, including tablets, capsules, syrups, dry suspensions & injectables. Such a range of products helps pharmaceutical brands extend their product range without extra capital investments.
Product Delivery & Regulatory Support
With its organized inventory system, Daffohils Laboratories guarantees timely dispatch of batches and a reliable delivery schedule. Moreover, their regulatory team assists with all necessary paperwork for quick DCGI approval.
Conclusion
Resolving operational challenges of pharma production requires choosing a competent third party pharma manufacturer with verified credentials. Collaboration with a trusted third-party pharma production partner allows avoiding quality risks, overcoming delays in inventory & protecting profit margins. Daffohils Laboratories offers WHO-GMP certified infrastructure, multi-level quality control, and full-scale regulatory support.
Collaboration with Daffohils Laboratories allows resolving common Third Party Manufacturing Challenges and ensuring efficient market expansion using third-party manufacturing.
Frequently Asked Questions (FAQs)
Q1. What Is Third Party Pharma Manufacturing?
Ans. Third party manufacturing is a business practice in which a company contracts a certified facility to Medicines Manufacture under its brand name.
Q2. How to Check the Manufacturer’s Quality Standards?
Ans. Examine laboratory facilities, batch inspection reports, and WHO-GMP and ISO certifications.
Q3. How Much Is the MOQ for Contract Manufacturing?
Ans. The minimum order quantity for third party manufacturing will depend on the dosage forms and will start from 30,000 tablets or 2,000 bottles for liquid forms.
Q4. How can I protect my formulation rights?
Ans. Make sure to have a non-disclosure agreement and contract prior to revealing your formulation.
Q5. What Documents Will Be Needed to Begin Contract Manufacturing?
Ans. A current drug license, GST registration, trademark approval, and a manufacturing agreement are all necessary.
Q6. How Does the Manufacturer Control Cross-Contamination Risk?
Ans. Special processing lines, AHU & automation machinery are used to safeguard the purity of the product.
Q7. What Is Average Manufacturing Cycle Time?
Ans. The manufacturing cycle in third party manufacturing takes 30 to 45 days on average, covering raw material testing, production & packaging.
Q8. Why Are Raw Material Costs Volatile in Contract Manufacturing?
Ans. Costs of active pharmaceutical ingredients depend on the supply of materials on the international market and import duties.
Q9. Can a Manufacturer Assist in the Design of My Product’s Package?
Ans. Yes, top manufacturers offer full support in package design, making it moisture-resistant in the form of ALU-ALU, blisters & bottles.